Acumen Pharmaceuticals Inc (ABOS)
2.31
-0.06
(-2.53%)
USD |
NASDAQ |
Nov 21, 16:00
2.305
0.00 (0.00%)
Pre-Market: 20:00
Acumen Pharmaceuticals Total Assets (Quarterly): 266.98M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 266.98M |
| June 30, 2024 | 288.91M |
| March 31, 2024 | 300.97M |
| December 31, 2023 | 310.12M |
| September 30, 2023 | 286.37M |
| June 30, 2023 | 177.40M |
| March 31, 2023 | 187.86M |
| December 31, 2022 | 196.59M |
| Date | Value |
|---|---|
| September 30, 2022 | 203.26M |
| June 30, 2022 | 211.68M |
| March 31, 2022 | 220.09M |
| December 31, 2021 | 230.33M |
| September 30, 2021 | 234.85M |
| June 30, 2021 | 72.94M |
| March 31, 2021 | 42.37M |
| December 31, 2020 | 44.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
42.37M
Minimum
Mar 2021
310.12M
Maximum
Dec 2023
204.70M
Average
215.88M
Median
Total Assets (Quarterly) Benchmarks
| Kodiak Sciences Inc | 372.67M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.77M |
| Shareholders Equity (Quarterly) | 217.20M |